おかえりなさい
Click “ログイン” to agree to Cointime’s 利用規約 and acknowledge that Cointime’s プライバシーポリシー applies to you.
アカウント登録
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">利用規約</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">プライバシーポリシー</a> applies to you.
siteでログインする
siteで登録する
あなたのメールアドレス
受信トレイを確認する
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Generate Biomedicines
company
About
Generate Biomedicines is a biotechnological company focusing on creating breakthrough medicines.
- Somerville,Massachusetts,United States
- 251 - 500
- https://generatebiomedicines.com
Details
- Last Funding Type
- Series B
- Last Funding Money Raised
- $370M
- Industries
- Biotechnology,Health Care,Medical,Product Research
- Founded date
- Jan 1, 2018
- Number Of Employee
- 251 - 500
- Operating Status
- Active
- Legal Name
- Generate Biomedicines, Inc.
- Also Known As
- Generate:Biomedicines
Generate Biomedicines is a biotechnological company focusing on creating breakthrough medicines. It pioneers in the field of Generative Biology, a revolutionary approach to drug development that allows them to program protein-based modalities for the first time.The company was founded in 2018 and is headquartered in Somerville, Massachusetts.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
$420M
Generate Biomedicines has raised a total of
$420M
in funding over 2 rounds. Their latest funding was raised on
Nov 18, 2021 from a Series B round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Nov 18, 2021 | Series B | $370M | 8 | — | — | Detail |
| Sep 10, 2020 | Series Unknown | $50M | 1 |
|
— | Detail |
Investments
Number of Investments
Number of Lead Investments
11
0
Generate Biomedicines has made 11 investments. Their most recent investment was on
Aug 31, 2021, when Syndicate raised $20M.
|
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
|---|---|---|---|---|
|
Aug 31, 2021
Syndicate
|
Series A | $20M | Cryptocurrency | — |
|
Feb 5, 2020
Transparent Financial Systems
|
Series A | $14M | Banking | — |
|
Oct 5, 2019
Haystack
|
Pre-seed | $2M | Human Resources | — |
|
Jan 24, 2019
Liquid Death
|
Seed | $1.60M | Food and Beverage | — |
|
Oct 23, 2018
Envoy
|
Series B | $43M | Facility Management | — |
Investors
Number of Lead Investors
Number of Investors
1
8
Generate Biomedicines is funded by 8 investors.
Abu Dhabi Investment Authority
and Alaska Permanent Fund
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Abu Dhabi Investment Authority
|
— | Series B |
Alaska Permanent Fund
|
— | Series B |
Altitude Life Science Ventures
|
— | Series B |
ARCH Venture Partners
|
— | Series B |
Fidelity Management and Research Company
|
— | Series B |
|
|
— | Series B |
Morningside Venture Investments
|
— | Series B |
T. Rowe Price
|
— | Series B |
Employee Profiles
Number of Employee Profiles
10
Generate Biomedicines has 10 current employee profiles, including
Executive Noubar Afeyan
Executive
Executive
Executive
Executive
Executive
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
